Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats (Q44071645)

29 November 2017

Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats (English)

1 reference

29 November 2017

1

Zofia Rogóz

1 reference

29 November 2017

2

Grazyna Skuza

1 reference

29 November 2017

4

Wojciech Danysz

1 reference

29 November 2017

Jerzy Maj

3

1 reference

29 November 2017

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

42

1 reference

29 November 2017

8

1 reference

29 November 2017

1024-1030

1 reference

Treatment-resistant depression

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Antidepressant effects of ketamine in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Role of the serotonergic system in the forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Is the forced swimming test a suitable model for revealing antidepressant activity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Amino-alkyl-cyclohexanes as a novel class of uncompetitive NMDA receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Possible use of amantadine in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. IV. Influence of haloperidol (R 1625) and of chlorpromazine on the behaviour of rats in an unfamiliar "open field" situation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Affinity of 1-aminoadamantanes for the σ binding site in post-mortem human frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

5-HT3 receptor antagonists reverse helpless behaviour in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Potential antidepressive properties of amantadine, memantine and bifemelane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Behavioural despair in rats: A new model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Antidepressants for the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Treatment resistant depression: methodological overview and operational criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

Amantadine in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900055-2

10.1016/S0028-3908(02)00055-2

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12128003